Melatonin Anticancer Effects: Review

A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers

(2012) E. S. Schernhammer et al.   CANCER CAUSES & CONTROL

The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials

(2012) Ye-min Wang et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Night Shift Work and Hormone Levels in Women

(2012) S. Davis et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Molecular mechanisms of melatonin’s inhibitory actions on breast cancers

(2012) Sara Proietti et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Melatonin, A Natural Programmed Cell Death Inducer in Cancer

(2012) M. Sánchez-Hidalgo et al.   CURRENT MEDICINAL CHEMISTRY

Combined effects of melatonin and all-trans retinoic acid and somatostatin on breast cancer cell proliferation and death: Molecular basis for the anticancer effect of these molecules

(2012) Martina Margheri et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines

(2012) Marina Sánchez-Hidalgo et al.   JOURNAL OF PINEAL RESEARCH

Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells

(2012) Virginia Alvarez-García et al.   JOURNAL OF PINEAL RESEARCH

Phenotypic changes caused by melatonin increased sensitivity of prostate cancer cells to cytokine-induced apoptosis

(2012) Aida Rodriguez-Garcia et al.   JOURNAL OF PINEAL RESEARCH

Melatonin suppresses tumor progression by reducing angiogenesis stimulated by HIF-1 in a mouse tumor model

(2012) Kil-Jung Kim et al.   JOURNAL OF PINEAL RESEARCH

Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B

(2012) Yu Sun et al.   NATURE MEDICINE

Radiation-Induced Reprogramming of Breast Cancer Cells

(2012) Chann Lagadec et al.   STEM CELLS

Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin

(2011) M. D. Mediavilla et al.   CURRENT MEDICINAL CHEMISTRY

Intracellular redox state as determinant for melatonin antiproliferative vs cytotoxic effects in cancer cells

(2011) Ana M. Sánchez-Sánchez et al.   FREE RADICAL RESEARCH

Melatonin as Adjuvant Cancer Care With and Without Chemotherapy

(2011) Dugald Seely et al.   INTEGRATIVE CANCER THERAPIES

Melatonin and Associated Signaling Pathways that Control Normal Breast Epithelium and Breast Cancer

(2011) Steven M. Hill et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Induction of cell differentiation and promotion of endocan gene expression in stomach cancer by melatonin

(2011) Sumei Zhang et al.   MOLECULAR BIOLOGY REPORTS

On the direct scavenging activity of melatonin towards hydroxyl and a series of peroxyl radicals

(2011) Annia Galano   PHYSICAL CHEMISTRY CHEMICAL PHYSICS

Clinical Uses of Melatonin: Evaluation of Human Trials

(2010) E.J. Sanchez-Barcelo et al.   CURRENT MEDICINAL CHEMISTRY

Melatonin suppresses tumor angiogenesis by inhibiting HIF-1α stabilization under hypoxia

(2010) Shi-Young Park et al.   JOURNAL OF PINEAL RESEARCH

Melatonin inhibits mitogenic cross-talk between retinoic acid-related orphan receptor alpha (RORα) and ERα in MCF-7 human breast cancer cells

(2010) Chunmin Dong et al.   STEROIDS

Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

(2009) H. Ghesquieres et al.   ANNALS OF ONCOLOGY

Chronic Lymphocytic Leukemia: Long-Lasting Remission with Combination of Cyclophosphamide, Somatostatin, Bromocriptine, Retinoids, Melatonin, and ACTH

(2009) Mauro Todisco   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Circulating Transforming Growth Factor-β in Marfan Syndrome

(2009) Peter Matt et al.   CIRCULATION

Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives

(2009) Stephen G. Grant et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells

(2009) Rainer Girgert et al.   JOURNAL OF PINEAL RESEARCH

Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells

(2009) Ignacio Bejarano et al.   JOURNAL OF PINEAL RESEARCH

The protective effect of melatonin on methamphetamine-induced calpain-dependent death pathway in human neuroblastoma SH-SY5Y cultured cells

(2009) Wilasinee Suwanjang et al.   JOURNAL OF PINEAL RESEARCH

ERK MAPK activation mediates the antiapoptotic signaling of melatonin in UVB-stressed U937 cells

(2008) F. Luchetti et al.   FREE RADICAL BIOLOGY AND MEDICINE

Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line

(2008) Mari Watanabe et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes

(2008) Javier G. Pizarro et al.   JOURNAL OF PINEAL RESEARCH

Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance

(2008) Chun W. Tam et al.   JOURNAL OF PINEAL RESEARCH

Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes

(2008) T. W. Fischer et al.   JOURNAL OF PINEAL RESEARCH

Melatonin prevents glucocorticoid inhibition of cell proliferation and toxicity in hippocampal cells by reducing glucocorticoid receptor nuclear translocation

(2008) Isabel Quiros et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY